Disc Medicine Inc (IRON)

Currency in USD
67.16
+0.34(+0.51%)
Real-time Data·
IRON is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
66.2468.41
52 wk Range
40.0099.50
Key Statistics
Prev. Close
66.82
Open
67.17
Day's Range
66.24-68.41
52 wk Range
40-99.5
Volume
60.17K
Average Vol. (3m)
517.69K
1-Year Change
41.3131%
Book Value / Share
18.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRON Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
101.09
Upside
+50.52%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period

Disc Medicine Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 101.09
(+50.52% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Buy80.00+18.71%75.00MaintainMay 14, 2026
Stifel
Buy111.00+64.71%-MaintainMar 30, 2026
Wells Fargo
Buy79.00+17.23%78.00MaintainMar 02, 2026
Stifel
Buy111.00+64.71%110.00MaintainFeb 27, 2026
Truist Securities
Buy83.00+23.16%114.00MaintainFeb 27, 2026

Disc Medicine Inc SWOT Analysis


Analyst Outlook
Learn about Cantor Fitzgerald's Overweight rating and price target of $132, reflecting confidence in Disc Medicine's growth potential.
Clinical Progress
Delve into upcoming data readouts for DISC-0974 in Phase 2 trials for myelofibrosis and Phase 1b studies for chronic kidney disease anemia.
Market Opportunity
Explore the expanded patient population for EPP/XLP and the substantial $5.5 billion market for myelofibrosis anemia treatments.
Promising Pipeline
Disc Medicine's bitopertin and DISC-0974 show potential in addressing unmet needs in EPP/XLP and myelofibrosis with anemia, respectively.
Read full SWOT analysis

Earnings

Latest Release
May 05, 2026
EPS / Forecast
-1.65 / -1.64
Revenue / Forecast
-- / 437.5K
EPS Revisions
Last 90 days

IRON Income Statement

Compare IRON to Peers and Sector

Metrics to compare
IRON
Peers
Sector
Relationship
P/E Ratio
−10.6x−6.1x−0.5x
PEG Ratio
0.150.020.00
Price / Book
3.7x4.6x2.6x
Price / LTM Sales
-47.8x3.1x
Upside (Analyst Target)
49.7%171.9%52.5%
Fair Value Upside
Unlock−10.7%6.0%Unlock

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.32M45.34%1.16B
Other Institutional Investors
31.21M54.66%2.09B
Public Companies & Retail Investors
0.000.00%0.00
Total
48.53M100.00%3.24B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC14.27%5,450,104364,176
Access Industries, Inc.7.37%2,814,379188,057

People Also Watch

2.020
GRI
-2.88%
2.025
SY
-9.19%
1.390
GPMT
+0.72%
225.25
UFPT
-1.62%
4.220
KRMD
+2.93%

FAQ

What Is the Disc Medicine (IRON) Stock Price Today?

The Disc Medicine stock price today is 67.16 USD.

What Stock Exchange Does Disc Medicine Trade On?

Disc Medicine is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Disc Medicine?

The stock symbol for Disc Medicine is "IRON."

What Is the Disc Medicine Market Cap?

As of today, Disc Medicine market cap is 2.58B USD.

What Is Disc Medicine's Earnings Per Share (TTM)?

The Disc Medicine EPS (TTM) is -6.60.

When Is the Next Disc Medicine Earnings Date?

Disc Medicine will release its next earnings report on Aug 06, 2026.

From a Technical Analysis Perspective, Is IRON a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Disc Medicine Stock Split?

Disc Medicine has split 1 times.

How Many Employees Does Disc Medicine Have?

Disc Medicine has 154 employees.

What is the current trading status of Disc Medicine (IRON)?

As of May 26, 2026, Disc Medicine (IRON) is trading at a price of 67.16 USD, with a previous close of 66.82 USD. The stock has fluctuated within a day range of 66.24 USD to 68.41 USD, while its 52-week range spans from 40.00 USD to 99.50 USD.

What Is Disc Medicine (IRON) Price Target According to Analysts?

The average 12-month price target for Disc Medicine is 101.09 USD, with a high estimate of 128 USD and a low estimate of 79 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +50.52% Upside potential.

What Is the IRON Premarket Price?

IRON's last pre-market stock price is 66.55 USD. The pre-market share volume is 610.00, and the stock has decreased by -0.27, or -0.40%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.